Home Does pain influence cognitive performance in patients with mild traumatic brain injury?
Article Open Access

Does pain influence cognitive performance in patients with mild traumatic brain injury?

  • Christian Oldenburg EMAIL logo , Aniko Bartfai and Marika C. Möller
Published/Copyright: June 21, 2024
Become an author with De Gruyter Brill

Abstract

Objectives

Pain is still a neglected problem in mild traumatic brain injury (mTBI). In this cross-sectional study, we examined the frequency of musculoskeletal pain in a sample of adult patients with persistent cognitive symptoms after mTBI and whether pain level affected cognition.

Methods

The participants were 23 adult patients aged 18–50 referred to brain injury rehabilitation clinics for neuropsychological assessment after having sustained an mTBI. A non-injured control group (n = 29) was recruited through advertisements. The patients were, on average, assessed 22 months after trauma. All participants completed a comprehensive neuropsychological test battery and completed the Örebro Musculoskeletal Pain Screening Questionnaire, The Rivermead Post-Concussion Symptoms Questionnaire, and the State-Trait Anxiety Inventory.

Results

Patients reported high levels of current pain and significantly more frequent neck and shoulder pain than the non-injured controls. Patients also reported high post-concussive symptoms and anxiety levels and performed less well on several neuropsychological tests. Pain level was associated with slower processing speed among the controls but not related to performance in the mTBI group.

Conclusion

We conclude that musculoskeletal pain is frequent in mTBI patients referred to rehabilitation settings. Furthermore, the results indicate that the interaction between pain and cognitive functioning differs in mTBI compared to controls. Our results implicate that pain screening should be an integrated part of neuropsychological rehabilitation after mTBI to identify conditions that run the risk of becoming chronic. The study was approved by the Regional Ethical Board in Stockholm, Sweden (04-415/2).

1 Introduction

Traumatic brain injury (TBI) has been defined as an “alteration in brain function, or other evidence of brain pathology, caused by an external force” [1]. TBI is a significant health concern with an annual estimated global incidence of approximately 50–60 million people [2]. The severity classification of TBI relies on presenting status, including the initial Glasgow Coma Scale score [3], duration of loss of consciousness, and post-traumatic amnesia [4]. Most TBIs (>90%) fall into the mild spectrum [5], commonly abbreviated as mild traumatic brain injury (mTBI). Individuals who suffer from an mTBI experience a wide range of acute symptoms, including physical, perceptual, cognitive, and emotional symptoms. In most cases, these symptoms are transient and gradually resolve within days or weeks after the injury [6]. However, for a significant minority of the mTBI population, some symptoms become persistent for months and even years [7,8,9]. Among the most frequent lingering symptoms is pain, especially headache [10,11].

Earlier, pain syndromes in this patient population were poorly characterized [12]. Bazarian et al. found that less than half of mTBI patients treated in emergency departments had any assessment and documentation of their pain [13]. In recent years, there has been growing attention to the issue of pain following TBI [14]. In a systematic review, Nampiaparampil reported a prevalence of chronic pain in TBI patients (n = 3,289) of approximately 52% [15]. Interestingly, the review also found that psychological disorders such as post-traumatic stress syndrome or depression were unrelated to chronic pain in these patients. Uomoto and Esselman described that mTBI patients reported significantly more headaches than patients with severe TBI [16]. Similar tendencies were found for neck/shoulder, back, and other pain syndromes [17].

Chronic pain defined as pain that persists or recurs for more than 3 months [18] has in general been associated with reduced cognitive function in several domains, including processing speed, executive functions, attention, and memory [19,20]. The level of pain seems to be related to the magnitude of cognitive impairment [21]. However, different underlying mechanisms contributing to the experience of pain may affect cognitive functions differently. Coppieters et al. [22] observed differences among women with whiplash-related chronic neck pain (WAD), idiopathic chronic neck pain, and women without neck pain. Both pain groups showed a lowered quality of life and cognitive functions compared to the healthy controls, but this decrease was more prominent in the WAD group. Specifically, the WAD group had poorer processing speed on an attention task (Trail Making Test [TMT]), memory functions, and general cognitive functions compared to patients with idiopathic neck pain without trauma. Furthermore, the authors found indications of central sensitization and interrelatedness among disability, cognitive deficits, and hyperalgesia in the WAD group. Other studies have found that patients diagnosed with localized chronic pain (e.g., injuries in the neck region) have both self-reported and verified explicit memory problems [23]. Studies have found that patients diagnosed with fibromyalgia exhibit deficits in working memory as well as impairments in both episodic and semantic memory [24].

Chronic pain and mTBI can often coexist and exhibit overlapping symptoms, making them challenging to distinguish based solely on reported symptoms. This means that an assessment of cognitive functions in mTBI patients that does not consider pain may misattribute deficits to brain injury rather than pain. However, the limited number of studies examining the relationship between TBI and chronic pain raises concerns [20]. Therefore, a holistic approach involving a multidisciplinary investigation of physiological, behavioral, cognitive, and emotional aspects is needed [25] as widespread pain assessed at 8 weeks is also a significant predictor for long-term (12-month) posttraumatic stress [26]. However, a study by McCracken and Iverson specifically examined the relationship between chronic pain and chronic cognitive impairment [27]. They found that symptoms overlapped and suggested that the presence of chronic pain should be considered in the interpretations of patients assessed after mTBI.

The current explorative study aimed to examine the frequency of self-reported musculoskeletal pain, and its relation to cognitive functions, measured with neuropsychological tests, in a consecutive sample of patients with mTBI. Additionally, the study aimed to investigate potential differences in how pain and mTBI may impact the pattern of cognitive performance.

2 Methods

This study has a cross-sectional design involving collaboration between two rehabilitation clinics for adult patients with acquired brain injuries.

2.1 Participants

The recruitment process was deeply integrated into the clinical framework. Referrals for neuropsychological assessments of mTBI patients mainly came from primary care physicians, but a minority of the cases also came from surgery or orthopedic clinics. The vast majority of individuals who met the inclusion criteria consented to participate, leading to negligible attrition between the stages of recruitment and completion of all study assessments. To qualify, patients needed to meet the American Congress of Rehabilitation Medicine’s mTBI criteria [28]. Injuries had to be recent but at least 3 months old.

Patients older than 50 years at the time of referral were excluded to reduce influences of age-related possible cognitive decline. At any ambiguity regarding acute clinical characteristics, such as alcohol intoxication at the time of injury, the patient was excluded from the study (n = 3). Intra-cranial injuries detected through imaging techniques were permissible, except for cases of subdural hematomas, which were considered a more severe injury. History of seizures or severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) or active substance abuse were also exclusion criteria. Participants had to be fluent in Swedish due to the testing requirements.

As orthopedic controls may potentially be predisposed to persistent pain due to their orthopedic injuries, a convenience sample of non-injured controls was collected through hospital advertisements and friends of staff to approximate the group-level match of patients for age, gender ratio, and education level. Eligibility criteria for the non-injured control group were 18–50 years of age, no history of brain injury, seizures or severe psychiatric disorders, and they had to be fluent in Swedish due to the testing requirements. Pain was not an exclusion criterion for inclusion in the control group, as we intended to compare the frequency of pain with the general population. The medical history of the controls was carefully inquired during their enrollment in the study. Due to our lack of authorization to access hospital records, the medical history of the control group could not be scrutinized. Given the low compensation level for participation (a small gift token), the incentive to participate was likely not financial, thereby reducing the risk of controls attempting to conceal symptoms to qualify for study involvement.

Of the initial 24 mTBI patients and 31 controls, three were excluded due to incomplete pain questionnaires. It should be noted that the absence of data from these three participants was due to an administrative oversight in questionnaire collection, and not due to incomplete responses. Due to the limited sample size, and since sex differences in self-reported pain have not been found in previous studies [25], results for men and women were not examined separately.

2.2 Sample size considerations

This study forms part of a comprehensive research project focused on long-term outcomes after mTBI. Our initial intention was to recruit a broader cohort but a change in the clinical protocol favoring patients with more severe TBI conditions limited the availability of eligible mTBI participants. To navigate this limitation, a power analysis was conducted in consultation with a statistician. This analysis focused on the Digit Symbol Test, recognized as the most sensitive cognitive measure within the study. It was determined that a sample size of 24 mTBI patients and 24 controls would suffice to detect an effect size of approximately 0.8 (Cohen’s D) given a mean difference of 2.5 and a standard deviation of 3.0, at an alpha level of 0.05, and with a power of 0.80.

2.3 Questionnaires and rating scales

2.3.1 California Concussion Scale (CCS)

This rating scale of mTBI severity can be administered retrospectively. Severity is graded on three variables: duration of PTA, loss of consciousness, and neurological symptoms. Scores range from 3 to 15. Lower scores reflect a more severe injury [29].

2.3.2 The Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

Participants’ experience of current (last 24 h) common symptoms following mTBI (e.g., dizziness, fatigue) was measured with the RPQ. The respondent is asked to rate each symptom on a 5-point scale, from 0 = not experienced at all to 4 = a severe problem. The patients were explicitly asked (as is customary) to compare with their preinjury baseline of each symptom. Non-injured controls use a modified RPQ, noting any symptoms in the past 24 h without a pre-injury baseline. The RPQ score is the sum of symptoms, excluding ratings of 1 (indicating past, resolved symptoms). Possible scores range from 0 to 64 [30].

2.3.3 The Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ)

The ÖMPSQ is a 25-item questionnaire that measures the experience of pain and psychological and social factors to predict chronic pain development [31]. The first seven items consist of background questions, the location of musculoskeletal pain (neck, shoulder, upper back, lower back, and legs), length of sickness absence from work (if any), and duration of pain. The remaining 18 items use a Likert scale format (0–10), with questions about pain levels, fear-avoidance beliefs, emotional states, coping, and activities of daily living. A cut-off score of 105 is used for establishing the risk of chronicity in patients with sub-acute pain. For this study, we created a special pain index by summating the three pain-level questions (current pain, average pain in the last 3 months, and frequency of pain).

2.3.4 State-Trait Anxiety Inventory (STAI)

The STAI is a commonly used measure of anxiety [32]. It measures anxiety with two subscales: state (current level) and trait (general level) anxiety. Scores range from 20 to 80.

2.4 Neuropsychological tests

2.4.1 Wechsler Adult Intelligence Scale – III (WAIS-III)

From the WAIS-III, we selected five tests: Information (Verbal comprehension), Matrix Reasoning (Perceptual organization), Digit Span and Letter-Number Sequencing (Working Memory), and Digit-Symbol (Processing speed) index (Wechsler, 2003). We also included the Block Span from WAIS-R Neuropsychological Instrument (NI) [33].

2.4.2 Selective Reminding Test (SRT)

The SRT [34,35] is a verbal learning test distinguishing between different memory components (e.g., short-term memory, long-term storage). The subject is presented with 12 words and is asked to recall as many as possible. In the subsequent trials, the subject is reminded only of those words they failed to recall in the immediately preceding trial. After the learning phase, the subject is asked to free recall the words after a 30-min delay. A cued recall and a multiple-choice condition are included.

2.4.3 TMT

The TMT measures visual scanning, graphomotor speed, and mental flexibility and consists of two parts, A and B [36]. Time in seconds to complete each part is presented.

2.4.4 Verbal fluency

In this test, the subject must produce as many words as possible with the same initial letter for 1 min. Three trials are administered, each with a different initial letter. The total score is the sum of all words for all trials [37].

2.4.5 Design fluency

Design fluency [38] is a nonverbal test, an alternative to verbal fluency. Subjects create designs with exactly four lines/components. Each unique design in 4 min earns a point [37].

2.4.6 The Rey 15-item memory test (FIT)

The FIT [39] was used as a short performance validity test. In this task, the subject is presented with a printed card for 10 s showing fifteen items. Recall is tested immediately after the exposure. A cut-off score <9 was used, as suggested by Lezak [36].

2.5 Procedure

Neuropsychologists assessed patients over three sessions, totaling 4–5 h, in outpatient clinic settings. The first session involved a structured interview about the accident to ensure eligibility criteria were met. At the end of this session, participants were provided with self-report questionnaires to be completed at home, allowing for a comprehensive reflection on their symptoms. They were instructed to return the completed questionnaires at the subsequent session, where they also underwent a neuropsychological test battery. Each returned questionnaire was carefully reviewed by the neuropsychologists to confirm completeness before proceeding. Non-injured controls underwent similar assessments but required only two sessions due to a less extensive history intake. They were compensated with a gift voucher and were offered an optional feedback session.

2.6 Statistical analysis

Statistical analysis involved descriptive statistics, t-tests, Mann–Whitney for skewed variables, and Levene’s test for variance. Nominal data used the chi-square test, with Fisher’s exact test for low frequencies. Associations between variables were assessed using Pearson or Spearman correlations. Effect sizes were reported as Cohen’s d or odds ratios with confidence intervals (CIs) for chi-square tests. An analysis of covariance (ANCOVA) assessed mTBI and control group differences, adjusting for education and pain. Analyses were two-tailed, with a 5% significance level, using SPSS version 28. Given the exploratory nature of our study, a Bonferroni correction was not applied to the multiple comparisons to avoid the increased risk of type II errors, which is particularly relevant in the context of limited sample size and correlated outcomes.

3 Results

3.1 Sociodemographic and injury characteristics

The gender ratio (male/female) was similar for the mTBI group and the non-injured controls with 12/11 (mTBI) and 12/17 (controls), χ 2(1) = 0.60, p = 0.438. The average age of the mTBI patients (M = 35.5, standard deviation [SD] = 9.9) was not significantly different from the non-injured controls (M = 36.6, SD = 8.8), t(50) = 0.44, p = 0.662. The mTBI group had on average fewer years of formal education (M = 12.0, SD = 1.5), compared to the non-injured controls (M = 13.1, SD = 2.0), t(50) = 2.37, p = 0.022. On average, mTBI patients were assessed 22.4 months after trauma (SD = 21.4, median = 18, range 4–75 months). The mean severity of the mTBI, as assessed by the CCS, was 11.1 (SD = 2.0), ranging from 8 to 14 points. Detailed injury characteristics for the mTBI patients can be seen in Table 1. None of the controls were using pain medications, whereas nearly half of the patients were using pain medications. The most common medication was paracetamol and/or a non-steroidal anti-inflammatory drug (n = 6); five patients used opioid-based drugs and one used pregabalin. One control used an SSRI antidepressant, and no one used sleep medication. Among the patients one used SSRI antidepressant, one used tricyclic antidepressants and two patients used sleep medication. Regarding marital status, 54% of the patients and 57% of the non-injured controls were married or lived together with a partner.

Table 1

Injury characteristics for patients with mTBI (n = 23)

Measure
Age at time of injury, M (SD) 33.9 (9.8)
Months from injury to assessment, M (SD) 22.4 (21.4)
 Range 4–75
CCS scores, M (SD)
 Post-traumatic amnesia 3.9 (1.4)
 Loss of consciousness 2.7 (1.2)
 Neurological signs 4.5 (0.6)
 Total 11.1 (2.0)
Retrograde amnesia, n (%) 7 (30.4)
Injury-related CT/MRI abnormalities, n (%) 4 (21.0)
Type of injury, n (%)
 Car accident 9 (39.1)
 Falls 7 (30.4)
 Bicycle or Motorbike accident 2 (8.7)
 Assault 2 (8.7)
 Hit by object 2 (8.7)
 Kicked by horse 1 (4.3)

CCS = California Concussion Scale. Imaging data were available for 19 patients. Signs of abnormality were found in four patients (intracranial hemorrhages = 3, fractured skull = 1). One patient had white matter lesions that the radiologist did not consider caused by the injury. Percentage calculation has been adjusted to reflect only those with imaging data.

3.2 Pain assessment

MTBI patients had a significantly higher total score in ÖMPSQ (M = 102.9, SD = 36.8) than the non-injured controls (M = 38.5, SD = 27.8), with a mean difference of 64.4, 95% CI [46.4–82.4], t(50) = 7.19, p < 0.001, d = 1.97. More than half (52%) of the mTBI patients scored over the clinical cut-off (>105) for high risk of chronic pain, compared to only 7% in the non-injured control group χ 2 = 13.37, p < 0.001. The mTBI patients reported the presence of musculoskeletal neck pain and shoulder pain significantly more frequently than the non-injured controls. No group differences were found concerning the presence of other musculoskeletal pain (upper back, lower back, and leg pain). The exact frequency of endorsement for the two groups can be seen in Table 2. On average, mTBI patients received a pain index score of 17.0 (SD = 7.1) compared to non-injured controls with a mean score of 4.6 (SD = 6.2), t(50) = 6.75, p < 0.001, d = 1.86. Means and standard deviations are presented for Likert scale items 8–25 in ÖMPSQ in Table 3.

Table 2

Proportions of musculoskeletal pain location as reported in the Örebro Musculoskeletal Screening Pain Questionnaire for patients with mTBI (mTBI) (n = 23) and non-injured controls (n = 29)

mTBI Controls χ 2 p OR 95% CI
n % N %
Neck 14 60.9 1 3.4 20.61 <0.001 43.6 5.0–378.9
Shoulder 13 56.5 3 10.3 12.84 <0.001 11.3 2.6–48.1
Upper back 5 21.7 1 3.4 4.20 0.076 7.8 0.8–72.1
Lower back 9 39.1 6 20.7 2.13 0.145 2.4 0.7–8.1
Legs 7 30.4 4 13.8 2.13 0.144 2.7 0.7–10.9

OR = odds ratio.

Table 3

Results from the Örebro Musculoskeletal Pain Screening Questionnaire for mTBI patients (n = 23), non-injured controls (n = 29), and a reference group of patients with acute and sub-acute pain (n = 107)

Item mTBI Controls p d Reference
M (SD) M (SD) M (SD)
8. Heavy work 4.2 (3.1) 2.7 (2.5) 0.077 0.53 5.1 (3.0)
9. Current pain 5.3 (2.7) 1.3 (2.0) 0.000 1.68 6.2 (2.1)
10. Average pain 5.8 (2.5) 1.8 (2.3) 0.000 1.67 5.1 (2.2)
11. Frequency of pain 5.9 (2.6) 1.6 (2.2) 0.000 1.79 6.1 (2.9)
12. Coping 5.8 (3.0) 3.5 (3.9) 0.019 0.66 5.0 (2.3)
13. Stress 5.1 (2.7) 2.4 (2.2) 0.000 1.10 5.0 (3.0)
14. Depression 3.9 (2.9) 2.0 (2.9) 0.029 0.66 3.4 (3.0)
15. Risk chronic 6.9 (3.0) 1.6 (2.8) 0.000 1.83 6.3 (2.9)
16. Chance working 4.3 (3.8) 0.6 (2.0) 0.000 1.22 0.9 (1.6)
17. Job satisfaction 2.9 (2.9) 2.8 (2.0) 0.937 0.04 2.9 (2.6)
18. Belief: increase 6.0 (3.7) 2.8 (3.8) 0.003 0.85 6.1 (3.4)
19. Belief: stop 6.3 (4.0) 5.6 (4.2) 0.571 0.17 6.9 (2.9)
20. Belief: not work 4.6 (4.0) 1.9 (3.4) 0.010 0.73 5.1 (3.4)
21. Light work 3.3 (3.0) 0.2 (0.7) 0.000 1.42 3.3 (2.9)
22. Walk 3.4 (3.7) 0.6 (1.9) 0.003 0.95 3.2 (3.3)
23. Household work 3.8 (2.7) 0.5 (1.6) 0.000 1.49 3.5 (3.9)
24. Shopping 3.4 (2.7) 0.6 (2.0) 0.000 1.18 3.6 (3.4)
25. Sleep 4.0 (2.8) 0.9 (2.3) 0.000 1.21 4.0 (2.9)

The values for the reference group are collected from Linton and Boersma [31] and consist of first visit ratings for patients with acute/subacute pain (duration <3 months).

3.3 Cognitive performance

None of the mTBI patients or controls failed the performance validity test, FIT, indicating an adequate effort on behalf of the examinees. For neuropsychological tests, mean values, standard deviations, comparisons, and effect sizes (Cohen’s d) are presented in Table 4. The mTBI group performed significantly lower in the neuropsychological tests, except for Information, the multiple-choice mode in the SRT, and the verbal and design fluency tests. Significant differences were found between patients and controls regarding years of education. ANCOVAs were therefore carried out to partially out the effect of this variable. When using years of education as a covariate, results were comparable to the uncorrected comparisons except for WAIS-III Matrix Reasoning and TMT-B (Table 4).

Table 4

Raw scores from the cognitive tests for patients with mTBI (n = 23) and non-injured controls (n = 29). For comparison Student’s t-test, Mann–Whitney was used. Additionally, ANCOVA with education as covariate was calculated

mTBI Controls t/U p d ANCOVA
Cognitive domain M SD M SD
Verbal comprehension
 WAIS-III Information 18.9 4.2 19.5 3.9 0.54 0.060 0.15 0.770
Perceptual organization
 WAIS-III Matrix Reasoning 18.0 4.5 21.0 3.6 2.67 0.010 0.74 0.068
Memory and learning
 SRT Total Recall 106.4 18.6 118.1 12.4 2.59 0.014 0.75 0.021
 SRT Consistent Recall 69.1 33.3 88.6 29.5 2.24 0.030 0.62 0.050
 SRT Delayed Recall 9.0 2.9 10.3 1.4 2.28 0.033 0.57 0.030
 SRT Cued Recall 9.8 1.7 11.0 1.1 3.02 0.005 0.84 0.008
 SRT Multiple Choice 11.4 1.5 11.9 0.4 285 0.537
Working Memory
 WAIS-III Digit Span 12.8 3.6 16.6 3.6 3.78 <0.001 1.06 0.002
 WAIS-III Letter Number seq. 9.0 2.2 11.2 2.3 3.48 0.001 0.98 0.002
 WAIS-R NI Block Span 15.3 4.3 18.5 2.9 3.14 0.003 0.87 0.002
Processing Speed
 WAIS-III Digit Symbol-Coding 63.9 15.2 82.2 14.1 4.47 <0.001 1.25 <0.001
 Trail Making Test, Part A 31.2 11.5 23.2 7.5 500 0.002
Executive function
 Trail Making Test, Part B 76.0 18.7 64.9 19.5 −2.08 0.043 0.58 0.082
 Verbal fluency 33.9 9.3 47.0 14.8 3.70 0.001 1.06 0.004
 Design Fluency 17.2 6.9 20.2 8.2 1.41 0.165 0.40 0.404

SRT = Selective Reminding test, WAIS = Wechsler Adult Intelligence Scale.

3.4 Post-concussion symptoms and anxiety

The mTBI patients reported, on average, 9.4 remaining post-concussive symptoms (SD = 4.1) and had an average score of 26.7 (SD = 12.8) in RPQ. The most frequently experienced symptoms in the mTBI group were fatigue 2.65 (SD = 1.56), poor concentration 2.57 (SD = 1.41). headaches 2.52 (SD = 1.41), and forgetfulness 2.35 (SD = 1.43). The controls reported few symptoms (M = 1.7, SD = 1.8, range 0–5) and had an average score of 3.8 (SD = 4.5), see Table 5. Both variables from the State-Trait Anxiety Inventory were skewed, so Mann–Whitney was used to examine group differences. The mTBI patients had significantly higher state anxiety (median 35) than controls (median 26), U = 498, z = 3.05, p = 0.002. They also had higher trait anxiety (median = 39) than the controls (median = 30), U = 493, z = 2.94, p = 0.003.

Table 5

Results from the Rivermead Post-Concussion Symptoms Questionnaire for patients with mTBI (n = 23)

Symptom M (SD) Frequency of endorsement, n (%)
No (0–1) Mild (2) Moderate (3) Severe (4)
Headaches 2.52 (1.41) 4 (17.4) 6 (26.1) 6 (26.1) 7 (30.4)
Dizziness 1.57 (1.50) 10 (43.5) 5 (21.7) 6 (26.1) 2 (8.7)
Nausea 0.68 (1.17) 17 (73.9) 3 (13.6) 3 (13.6) 0 (0.0)
Noise sensitivity 2.09 (1.41) 6 (26.1) 6 (26.1) 8 (34.8) 3 (13.0)
Sleep disturbance 1.91 (1.44) 7 (30.4) 7 (30.4) 6 (26.1) 3 (13.0)
Fatigue 2.65 (1.56) 5 (21.7) 2 (8.7) 7 (30.4) 9 (39.1)
Irritability 1.70 (1.43) 8 (34.8) 9 (39.1) 3 (13.0) 3 (13.0)
Feeling depressed 1.09 (1.41) 14 (60.9) 4 (18.2) 4 (18.2) 1 (4.5)
Feeling frustrated 1.48 (1.53) 11 (47.8) 4 (17.4) 6 (26.1) 2 (8.7)
Forgetfulness 2.35 (1.43) 5 (21.7) 5 (21.7) 8 (34.8) 5 (21.7)
Poor concentration 2.57 (1.41) 4 (17.4) 5 (21.7) 7 (30.4) 7 (30.4)
Taking longer to think 1.96 (1.43) 7 (30.4) 5 (21.7) 9 (39.1) 2 (8.7)
Blurred vision 0.87 (1.29) 15 (65.2) 5 (21.7) 2 (8.7) 1 (4.3)
Light sensitivity 1.13 (1.25) 12 (52.2) 7 (30.4) 4 (17.4) 0 (0.0)
Double vision 0.65 (1.19) 17 (73.9) 4 (17.4) 1 (4.3) 1 (4.3)
Restlessness 1.52 (1.34) 9 (39.1) 8 (34.8) 5 (21.7) 1 (4.3)

All ratings of 1, which indicates a previous symptom no longer present, were set to zero before calculations of means and standard deviations.

3.5 Associations with pain in the mTBI group

Pain index was not associated with cognitive performance in any of the neuropsychological tests. On the other hand, pain index showed positive associations with both trait anxiety (r = 0.52, p < 0.001), state anxiety (r = 0.45, p = 0.001), and the total score in RPQ (r = 0.46, p = 0.026). Additionally, a negative association was observed between pain index and injury severity as measured by the CCS, indicating higher pain with less severe injury (r = 0.47, p = 0.024).

3.6 Associations with pain in the control group

Pain index was associated with worse cognitive performance in some of the neuropsychological tests, specifically with Digit Symbol (r = −0.47, p = 0.011), Trail Making A (r = 0.43, p = 0.022), and the number of correct words produced in Verbal fluency (r = −0.50, p = 0.005). However, pain index did not show associations with either state or trait anxiety or the total score in RPQ.

4 Discussion

The primary objective of this study was to investigate the prevalence of musculoskeletal pain in patients who experienced persistent cognitive complaints following an mTBI, in comparison to non-injured controls. Further, possible differences between patients and controls were examined with regard to how pain interacts with cognition. Chronic mTBI patients reported a remarkably high extent of headache and neck/shoulder pain, in the range of what patients with primarily acute or subacute pain report [31,40]. Higher pain level was associated with less severe injury, higher anxiety, and higher self-rated post-concussion symptoms.

The mTBI patients performed less well in the neuropsychological assessment than the non-injured controls. The most marked deficits were noted on tests measuring processing speed and working memory, but the neuropsychological test results were not related to pain among the patients. Pain was, however, associated with higher anxiety levels and higher reports of post-concussion symptoms. However, comparing self-reported data with cognitive test performance presents a general methodological challenge, as shown in a series of studies [41]. Intercorrelations among self-ratings may suggest distinctive response patterns, where some individuals tend to provide extreme estimates, while others tend to remain around the average. However, this does not necessarily imply significant differences in the actual symptoms experienced.

In controls, higher pain was associated with slower processing speed, but no associations were found between pain and anxiety and post-concussion symptoms. The association between pain and processing speed among the controls is in line with previous findings regarding pain and cognitive functions [20,42]. In the mTBI group, the absence of these associations may reflect a disrupted neurocognitive anticipatory pain network [43]. The pain modulatory systems in the brain are physiologically linked to the same regions in the brain stem which often are affected by a traumatic brain injury [15,44].

In the present study, 83% of patients with mTBI reported suffering from headaches, and 57–61% reported neck and shoulder pain. These results are in line with Uomoto and Esselman’s study [16], where the frequency of headache was 89%, neck/shoulder 51 and 45%, and other pain localizations 20%. The Mollayeva et al. study [25] also reported high frequencies of similar pain localizations in mTBI patients.

Previous epidemiological research has found that approximately 5% of individuals in the workforce have isolated neck and shoulder pain [45], which corresponds broadly to the 3–10% neck and shoulder pain we observed in the non-injured control group of our study. Other pain areas, such as the upper back, lower back, and legs, were not significantly different. In this study, we utilized the ÖMPSQ, a tool developed to measure musculoskeletal pain that measures the subjective experience of pain and psychological and social factors to predict the development of chronic pain [31]. The localized pain pattern, concentrated on the head, neck and shoulders, may be attributed to the specific nature of the injury and associated stressful events [17].

Higher pain was associated with a less severe injury. The inverse relationship between pain and severity of TBI has previously been demonstrated in studies, where mTBI patients report more headaches than patients with moderate and severe TBI [15,16,46]. Our study shows that this relationship also holds within the current mTBI group. According to one hypothesis regarding the differential reporting of pain, cognitive and executive impairments in moderate and severe TBI interfere with adequate self-perception and communication [15]. However, we found differences within the present mTBI sample where this explanation seems unlikely. Our tentative hypothesis is that selection bias instead can create this effect in mTBI samples. The largest group of the mTBI spectrum is the very mild mTBI. In these cases, high symptom reporting, including pain, may be required to motivate referrals, thereby aggregating higher pain and symptom reporting in clinical samples. The anxiety level was significantly higher in mTBI patients, in line with earlier findings [47]. Anxiety was related to pain but not to patients’ cognitive performance, as Weyer Jamora and colleagues have previously reported [48].

The patient’s primary cognitive complaint was the main reason for the referral to a neuropsychological assessment. Overall, the mTBI patients performed more poorly on neuropsychological tests, also after controlling for educational level. The tests measuring processing speed and working memory revealed the most significant deficits. This finding is in line with previous studies of clinical samples where moderate effects on cognition are usually observed [49] but also in line with patients suffering from chronic pain [42].

There are several theoretical models to explain cognitive dysfunction in chronic pain. One such model is the limited resource theory, which posits that pain signals disrupt attention and executive processing due to shared structures between pain and attention networks in the brain [50,51]. Another model, “the neuroplasticity theory” has been proposed as an explanation as studies have found pain-related changes in the brain. Studies on both structural and functional levels have found abnormalities in regions involved in attention and executive functioning. These regions include the anterior cingulate cortex (ACC) and prefrontal cortex, which exhibit abnormalities in grey matter volume in patients with chronic pain [52,53], as well as abnormal regional cerebral blood flow in the ACC, caudate nucleus, and thalamus [54].

To expand on this topic, additional studies have found that mTBI might be a vulnerability factor for developing various pain-related conditions, even when controlling for related emotional symptoms [43]. Changes in periaqueductal grey activation following mTBI appear to modulate pain processing and tone and affect the degree of the perceived pain intensity. Furthermore, individual differences in pain vulnerability are associated with smaller amygdala size in the sub-acute stage for patients with lower back pain, as shown by Vachon-Presseau and colleagues [55,56]. Clinically, it can be challenging to sort out what causes what, nevertheless, the neuropsychological assessment reflects the patient’s actual impairments.

Our findings have clinical implications since both assessment and treatment of pain are often overlooked in the treatment of mTBI patients. Differences between patients and controls in our study regarding the relation between self-rated pain and cognition caution us against generalizing conclusions based on other chronic pain groups or healthy subjects to patients with mTBI. Pain seems to impair processing speed, but it does not exclude impaired cognitive performance in mTBI patients due to the injury itself or to other factors (psychosocial or emotional). Our results concerning neuropsychological assessment imply that the complex interactive effects of cognitive deficits, pain, and anxiety cannot be disentangled solely with neuropsychological instruments. There is thus a need for a more multidisciplinary approach with additional biological or neuroimaging markers. If the pain among mTBI patients is neglected, it might hamper the effect of cognitive rehabilitation. A multifactorial approach is, therefore, essential.

This study has limitations. First, the sample size of the mTBI group is relatively small, which may increase the risk of type II error. However, despite these limitations, a clear pattern emerged. Second, the broad time frame post-injury for inclusion in the study, ranging from 4 to 75 months, may have resulted in a heterogeneous sample. Future studies would benefit from a more restricted post-injury time frame as an inclusion criterion. Additionally, we did not employ Bonferroni adjustments for multiple comparisons, which can elevate the risk of type I error. While this was a deliberate choice to prevent significant findings to be obscured in our exploratory research, it necessitates a cautious interpretation of the significance levels reported. Future studies may seek to apply more stringent statistical corrections.

Moreover, while the participants in our study sought help for post-concussive symptoms that had persisted for months, even years post-injury, they do not represent all individuals who seek care immediately after an mTBI. This distinction is critical as it separates our sample from those who may experience different recovery trajectories, including those who never seek any subsequent care at all, apart from emergency department care. This selection biases our sample towards individuals with more chronic or long-term issues leading to their presentation in clinical settings. Consequently, while the findings are highly relevant for practitioners and reflect the patient profiles typically encountered in clinical practice, they may not generalize to the entire population of those who have sustained an mTBI. Prospective studies should aim to capture the full spectrum of mTBI experiences by including individuals with varied post-injury care-seeking behaviors.

A third limitation is that pain reports were solely based on symptom reports, which prevented further analysis of the pain’s specificity, onset, and its association with the event that caused the mTBI.

Another limitation of our study is that many patients were using pain medication, which could have affected their cognitive functioning. Subanalyses on the effects of these medications were not feasible due to the limited power of our study. Consequently, no definitive conclusions can be drawn regarding the impact of medication on the results.

It is also important to acknowledge an administrative oversight that resulted in the non-collection of three participants’ questionnaires, an error that was addressed in subsequent procedures to ensure data completeness. Despite this, the data analyzed did not contain missing responses.

This study also has strengths. First, the mTBI patients were consecutively enrolled. Thus, the findings reflect complaints of patients routinely seen in rehabilitation settings. Second, we used a broad measure of pain that encompassed current pain, average as well as pain in the last 3 months, and pain frequency. Third, the neuropsychological assessment was comprehensive and performed by experienced clinical neuropsychologists.

To conclude, mTBI patients with persistent cognitive symptoms endorse the prevalence of headache and neck and shoulder pains to a similar extent as subacute musculoskeletal pain patients. Still, in our study, mTBI patients did not report pain in other locations. Furthermore, the mTBI group exhibited significant cognitive impairment in the domains of processing speed and working memory. However, unlike controls, cognitive impairment in the mTBI group was not related to the reported pain level. In controls, there was a correlation between processing speed and pain level.

According to our results, musculoskeletal pain should be considered in rehabilitation settings where mTBI patients are treated. Additionally, given the shared underlying brain mechanisms involved in working memory, processing speed, pain, and anxiety, a combination of treatment approaches in mTBI or chronic pain rehabilitation is recommended. Examples of a treatment program might be a combination of intensive cognitive training [57], controlled aerobic exercise [58], and psychoeducative approaches [59].

Acknowledgments

The authors thank the patients for their participation in the study, and the clinical staff for assisting in the recruitment of healthy controls. We would also like to acknowledge Thomas Lundeberg, docent, for collaboration on an earlier version of this manuscript.

  1. Research ethics: Research involving human subjects complied with all relevant national regulations, institutional policies, and is in accordance with the tenets of the Helsinki Declaration (as amended in 2013) and has been approved by the Regional Ethical Board in Stockholm, Sweden.

  2. Informed consent: Prior to participation, all individuals were provided with verbal and written information regarding the study. Moreover, signed consent forms were obtained from all participants.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: This study has been supported by the Centre for Clinical Research Sörmland, Uppsala University and the Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet.

  6. Data availability: The raw data supporting the conclusions of this article will be made available by the authors on reasonable request to corresponding author.

  7. Artificial intelligence/Machine learning tools: Not applicable.

References

[1] Menon DK, Schwab K, Wright DW, Maas AI. Demographics, clinical assessment working group of the I, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637–40.10.1016/j.apmr.2010.05.017Search in Google Scholar PubMed

[2] Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987–1048.10.1016/S1474-4422(17)30371-XSearch in Google Scholar PubMed

[3] Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4.10.1016/S0140-6736(74)91639-0Search in Google Scholar

[4] Carroll LJ, Cassidy JD, Holm L, Kraus J, Coronado VG. Injury WHOCCTFoMTB. Methodological issues and research recommendations for mild traumatic brain injury: the WHO collaborating centre task force on Mild Traumatic brain injury. J Rehabil Med. 2004;43 Suppl:113–25.10.1080/16501960410023877Search in Google Scholar PubMed

[5] Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, et al. Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol. 2013;12(1):53–64.10.1016/S1474-4422(12)70262-4Search in Google Scholar PubMed

[6] Carroll LJ, Cassidy JD, Peloso PM, Borg J, von Holst H, Holm L, et al. Prognosis for mild traumatic brain injury: results of the WHO collaborating centre task force on Mild Traumatic brain injury. J Rehabil Med. 2004;43 Suppl:84–105.10.1080/16501960410023859Search in Google Scholar PubMed

[7] McMahon P, Hricik A, Yue JK, Puccio AM, Inoue T, Lingsma HF, et al. Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study. J Neurotrauma. 2014;31(1):26–33.10.1089/neu.2013.2984Search in Google Scholar PubMed PubMed Central

[8] Lundin A, de Boussard C, Edman G, Borg J. Symptoms and disability until 3 months after mild TBI. Brain Inj. 2006;20(8):799–806.10.1080/02699050600744327Search in Google Scholar PubMed

[9] Carroll EL, Outtrim JG, Forsyth F, Manktelow AE, Hutchinson PJA, Tenovuo O, et al. Mild traumatic brain injury recovery: a growth curve modelling analysis over 2 years. J Neurol. 2020;267(11):3223–34.10.1007/s00415-020-09979-xSearch in Google Scholar PubMed PubMed Central

[10] Voormolen DC, Haagsma JA, Polinder S, Maas AIR, Steyerberg EW, Vuleković P, et al. Post-concussion symptoms in complicated vs uncomplicated mild traumatic brain injury patients at three and six months post-injury: Results from the CENTER-TBI study. J Clin Med. 2019;8(11):1921.10.3390/jcm8111921Search in Google Scholar PubMed PubMed Central

[11] Lannsjo M, Geijerstam JL, Johansson U, Bring J, Borg J. Prevalence and structure of symptoms at 3 months after mild traumatic brain injury in a national cohort. Brain Inj. 2009;23(3):213–9.10.1080/02699050902748356Search in Google Scholar PubMed

[12] Tenovuo O. Central pain after brain trauma–a neglected problem in neglected victims. Pain. 2007;131(3):241–2.10.1016/j.pain.2007.07.003Search in Google Scholar PubMed

[13] Bazarian JJ, McClung J, Cheng YT, Flesher W, Schneider SM. Emergency department management of mild traumatic brain injury in the USA. Emerg Med J. 2005;22(7):473–7.10.1136/emj.2004.019273Search in Google Scholar PubMed PubMed Central

[14] Grandhi R, Tavakoli S, Ortega C, Simmonds MJ. A review of chronic pain and cognitive, mood, and motor dysfunction following mild traumatic brain injury: Complex, comorbid, and/or overlapping conditions? Brain Sci. 2017;7(12):160.10.3390/brainsci7120160Search in Google Scholar PubMed PubMed Central

[15] Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. Jama. 2008;300(6):711–9.10.1001/jama.300.6.711Search in Google Scholar PubMed

[16] Uomoto JM, Esselman PC. Traumatic brain injury and chronic pain: differential types and rates by head injury severity. Arch Phys Med Rehabil. 1993;74(1):61–4.Search in Google Scholar

[17] King PR, Beehler GP, Wade MJ. Self-reported pain and pain management strategies among veterans with traumatic brain injury: A pilot study. Mil Med. 2015;180(8):863–8.10.7205/MILMED-D-14-00472Search in Google Scholar PubMed

[18] Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain. 2019;160(1):19–27.10.1097/j.pain.0000000000001384Search in Google Scholar PubMed

[19] Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011;93(3):385–404.10.1016/j.pneurobio.2011.01.002Search in Google Scholar PubMed

[20] Higgins DM, Martin AM, Baker DG, Vasterling JJ, Risbrough V. The relationship between chronic pain and neurocognitive function: A systematic review. Clin J Pain. 2018;34(3):262–75.10.1097/AJP.0000000000000536Search in Google Scholar PubMed PubMed Central

[21] Eccleston C, Crombez G, Aldrich S, Stannard C. Attention and somatic awareness in chronic pain. Pain. 1997;72(1–2):209–15.10.1016/S0304-3959(97)00030-4Search in Google Scholar

[22] Coppieters I, De Pauw R, Kregel J, Malfliet A, Goubert D, Lenoir D, et al. Differences between women with traumatic and idiopathic chronic neck pain and women without neck pain: Interrelationships among disability, cognitive deficits, and central sensitization. Phys Ther. 2017;97(3):338–53.Search in Google Scholar

[23] Grisart JM, Van der Linden M. Conscious and automatic uses of memory in chronic pain patients. Pain. 2001;94(3):305–13.10.1016/S0304-3959(01)00366-9Search in Google Scholar PubMed

[24] Glass JM. Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheumatic Dis Clin North Am. 2009;35(2):299–311.10.1016/j.rdc.2009.06.002Search in Google Scholar PubMed

[25] Mollayeva T, Cassidy JD, Shapiro CM, Mollayeva S, Colantonio A. Concussion/mild traumatic brain injury-related chronic pain in males and females: A diagnostic modelling study. Medicine (Baltimore). 2017;96(7):e5917.10.1097/MD.0000000000005917Search in Google Scholar PubMed PubMed Central

[26] Hellstrom T, Kaufmann T, Andelic N, Soberg HL, Sigurdardottir S, Helseth E, et al. Predicting outcome 12 months after mild traumatic brain injury in patients admitted to a neurosurgery service. Front Neurol. 2017;8:125.10.3389/fneur.2017.00125Search in Google Scholar PubMed PubMed Central

[27] McCracken LM, Iverson GL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage. 2001;21(5):392–6.10.1016/S0885-3924(01)00267-6Search in Google Scholar

[28] Na Na. Definition of mild traumatic brain injury. J Head Trauma Rehabil. 1993;8(3):86–7.10.1097/00001199-199309000-00010Search in Google Scholar

[29] Ruff R. Two decades of advances in understanding of mild traumatic brain injury. J Head Trauma Rehabil. 2005;20(1):5–18.10.1097/00001199-200501000-00003Search in Google Scholar PubMed

[30] King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The rivermead post concussion symptoms questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242(9):587–92.10.1007/BF00868811Search in Google Scholar PubMed

[31] Linton SJ, Boersma K. Early identification of patients at risk of developing a persistent back problem: the predictive validity of the Orebro Musculoskeletal Pain Questionnaire. Clin J Pain. 2003;19(2):80–6.10.1097/00002508-200303000-00002Search in Google Scholar PubMed

[32] Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.Search in Google Scholar

[33] Kaplan E. Fein, Morris, Delis. WAIS-R as a neuropsychological instrument. San Antonio: The Psychological Corporation; 1991.Search in Google Scholar

[34] Buschke H. Selective reminding for analysis of memory and learning. J Verbal Learn Verbal Behav. 1973;12(5):543–50.10.1016/S0022-5371(73)80034-9Search in Google Scholar

[35] Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24(11):1019–25.10.1212/WNL.24.11.1019Search in Google Scholar

[36] Lezak MD. Neuropsychological assessment. 5th edn. Oxford; New York: Oxford University Press; 2012. p. 1161.Search in Google Scholar

[37] Lezak MD, Howieson DB, Bigler ED. Tranel D. Neuropsychological assessment. 5th edn. New York: Oxford University Press; 2012.Search in Google Scholar

[38] Jones-Gotman M, Milner B. Design fluency: the invention of nonsense drawings after focal cortical lesions. Neuropsychologia. 1977;15(4–5):653–74.10.1016/0028-3932(77)90070-7Search in Google Scholar PubMed

[39] Rey A. The clinical examination in psychology. Paris: University Press of France; 1964.Search in Google Scholar

[40] Guez M, Hildingsson C, Nilsson M, Toolanen G. The prevalence of neck pain: a population-based study from northern Sweden. Acta Orthop Scand. 2002;73(4):455–9.10.1080/00016470216329Search in Google Scholar PubMed

[41] Nelson A, Gavelin HM, Boraxbekk CJ, Eskilsson T, Josefsson M, Slunga Järvholm L, et al. Subjective cognitive complaints in patients with stress-related exhaustion disorder: a cross sectional study. BMC Psychol. 2021;9(1):84.10.1186/s40359-021-00576-9Search in Google Scholar PubMed PubMed Central

[42] Moriarty O, Finn DP. Cognition and pain. Curr Opin Support Palliat Care. 2014;8(2):130–6.10.1097/SPC.0000000000000054Search in Google Scholar PubMed

[43] Strigo IA, Spadoni AD, Lohr J, Simmons AN. Too hard to control: compromised pain anticipation and modulation in mild traumatic brain injury. Transl Psychiatry. 2014;4(1):e340.10.1038/tp.2013.116Search in Google Scholar PubMed PubMed Central

[44] Widerstrom-Noga E, Govind V, Adcock JP, Levin BE, Maudsley AA. Subacute pain after traumatic brain injury is associated with lower insular N-acetylaspartate concentrations. J Neurotrauma. 2016;33(14):1380–9.10.1089/neu.2015.4098Search in Google Scholar PubMed PubMed Central

[45] Sarquis LMM, Coggon D, Ntani G, Walker-Bone K, Palmer KT, Felli VE, et al. Classification of neck/shoulder pain in epidemiological research: a comparison of personal and occupational characteristics, disability, and prognosis among 12,195 workers from 18 countries. Pain. 2016;157(5):1028–36.10.1097/j.pain.0000000000000477Search in Google Scholar PubMed PubMed Central

[46] Hoffman JM, Lucas S, Dikmen S, Braden CA, Brown AW, Brunner R, et al. Natural history of headache after traumatic brain injury. J Neurotrauma. 2011;28(9):1719–25.10.1089/neu.2011.1914Search in Google Scholar PubMed PubMed Central

[47] Oldenburg C, Lundin A, Edman G, Deboussard CN, Bartfai A. Emotional reserve and prolonged post-concussive symptoms and disability: a Swedish prospective 1-year mild traumatic brain injury cohort study. BMJ Open. 2018;8(7):e020884.10.1136/bmjopen-2017-020884Search in Google Scholar PubMed PubMed Central

[48] Weyer Jamora C, Schroeder SC, Ruff RM. Pain and mild traumatic brain injury: the implications of pain severity on emotional and cognitive functioning. Brain Inj. 2013;27(10):1134–40.10.3109/02699052.2013.804196Search in Google Scholar PubMed

[49] Belanger HG, Curtiss G, Demery JA, Lebowitz BK, Vanderploeg RD. Factors moderating neuropsychological outcomes following mild traumatic brain injury: a meta-analysis. J Int Neuropsychol Soc. 2005;11(3):215–27.10.1017/S1355617705050277Search in Google Scholar PubMed

[50] Grisart J, Van der Linden M, Masquelier E. Controlled processes and automaticity in memory functioning in fibromyalgia patients: relation with emotional distress and hypervigilance. J Clin Exp Neuropsychol. 2002;24(8):994–1009.10.1076/jcen.24.8.994.8380Search in Google Scholar PubMed

[51] Legrain V, Damme SV, Eccleston C, Davis KD, Seminowicz DA, Crombez G. A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain. 2009;144(3):230–2.10.1016/j.pain.2009.03.020Search in Google Scholar PubMed

[52] Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24(46):10410–5.10.1523/JNEUROSCI.2541-04.2004Search in Google Scholar PubMed PubMed Central

[53] Luerding R, Weigand T, Bogdahn U, Schmidt-Wilcke T. Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain. 2008;131(Pt 12):3222–31.10.1093/brain/awn229Search in Google Scholar PubMed

[54] Staud R, Domingo M. Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med. 2001;2(3):208–15.10.1046/j.1526-4637.2001.01030.xSearch in Google Scholar PubMed

[55] Vachon-Presseau E, Tetreault P, Petre B, Huang L, Berger SE, Torbey S, et al. Corticolimbic anatomical characteristics predetermine risk for chronic pain. Brain. 2016;139(Pt 7):1958–70.10.1093/brain/aww100Search in Google Scholar PubMed PubMed Central

[56] Vachon-Presseau E, Centeno MV, Ren W, Berger SE, Tetreault P, Ghantous M, et al. The emotional brain as a predictor and amplifier of chronic pain. J Dent Res. 2016;95(6):605–12.10.1177/0022034516638027Search in Google Scholar PubMed PubMed Central

[57] Cicerone KD, Goldin Y, Ganci K, Rosenbaum A, Wethe JV, Langenbahn DM, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100(8):1515–33.10.1016/j.apmr.2019.02.011Search in Google Scholar PubMed

[58] Carter KM, Pauhl AN, Christie AD. The role of active rehabilitation in concussion management: a systematic review and meta-analysis. Med Sci Sports Exerc. 2021;53(9):1835–45.10.1249/MSS.0000000000002663Search in Google Scholar PubMed

[59] Möller MC, Lexell J, Wilbe Ramsay K. Effectiveness of specialized rehabilitation after mild traumatic brain injury: A systematic review and meta-analysis. J Rehabil Med. 2021;53(2):jrm00149-jrm.10.2340/16501977-2791Search in Google Scholar PubMed PubMed Central

Received: 2023-10-23
Revised: 2024-03-18
Accepted: 2024-05-13
Published Online: 2024-06-21

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Editorial Comment
  2. From pain to relief: Exploring the consistency of exercise-induced hypoalgesia
  3. Christmas greetings 2024 from the Editor-in-Chief
  4. Original Articles
  5. The Scandinavian Society for the Study of Pain 2022 Postgraduate Course and Annual Scientific (SASP 2022) Meeting 12th to 14th October at Rigshospitalet, Copenhagen
  6. Comparison of ultrasound-guided continuous erector spinae plane block versus continuous paravertebral block for postoperative analgesia in patients undergoing proximal femur surgeries
  7. Clinical Pain Researches
  8. The effect of tourniquet use on postoperative opioid consumption after ankle fracture surgery – a retrospective cohort study
  9. Changes in pain, daily occupations, lifestyle, and health following an occupational therapy lifestyle intervention: a secondary analysis from a feasibility study in patients with chronic high-impact pain
  10. Tonic cuff pressure pain sensitivity in chronic pain patients and its relation to self-reported physical activity
  11. Reliability, construct validity, and factorial structure of a Swedish version of the medical outcomes study social support survey (MOS-SSS) in patients with chronic pain
  12. Hurdles and potentials when implementing internet-delivered Acceptance and commitment therapy for chronic pain: a retrospective appraisal using the Quality implementation framework
  13. Exploring the outcome “days with bothersome pain” and its association with pain intensity, disability, and quality of life
  14. Fatigue and cognitive fatigability in patients with chronic pain
  15. The Swedish version of the pain self-efficacy questionnaire short form, PSEQ-2SV: Cultural adaptation and psychometric evaluation in a population of patients with musculoskeletal disorders
  16. Pain coping and catastrophizing in youth with and without cerebral palsy
  17. Neuropathic pain after surgery – A clinical validation study and assessment of accuracy measures of the 5-item NeuPPS scale
  18. Translation, contextual adaptation, and reliability of the Danish Concept of Pain Inventory (COPI-Adult (DK)) – A self-reported outcome measure
  19. Cosmetic surgery and associated chronic postsurgical pain: A cross-sectional study from Norway
  20. The association of hemodynamic parameters and clinical demographic variables with acute postoperative pain in female oncological breast surgery patients: A retrospective cohort study
  21. Healthcare professionals’ experiences of interdisciplinary collaboration in pain centres – A qualitative study
  22. Effects of deep brain stimulation and verbal suggestions on pain in Parkinson’s disease
  23. Painful differences between different pain scale assessments: The outcome of assessed pain is a matter of the choices of scale and statistics
  24. Prevalence and characteristics of fibromyalgia according to three fibromyalgia diagnostic criteria: A secondary analysis study
  25. Sex moderates the association between quantitative sensory testing and acute and chronic pain after total knee/hip arthroplasty
  26. Tramadol-paracetamol for postoperative pain after spine surgery – A randomized, double-blind, placebo-controlled study
  27. Cancer-related pain experienced in daily life is difficult to communicate and to manage – for patients and for professionals
  28. Making sense of pain in inflammatory bowel disease (IBD): A qualitative study
  29. Patient-reported pain, satisfaction, adverse effects, and deviations from ambulatory surgery pain medication
  30. Does pain influence cognitive performance in patients with mild traumatic brain injury?
  31. Hypocapnia in women with fibromyalgia
  32. Application of ultrasound-guided thoracic paravertebral block or intercostal nerve block for acute herpes zoster and prevention of post-herpetic neuralgia: A case–control retrospective trial
  33. Translation and examination of construct validity of the Danish version of the Tampa Scale for Kinesiophobia
  34. A positive scratch collapse test in anterior cutaneous nerve entrapment syndrome indicates its neuropathic character
  35. ADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHD
  36. The relationship between changes in pain intensity and functional disability in persistent disabling low back pain during a course of cognitive functional therapy
  37. Intrathecal pain treatment for severe pain in patients with terminal cancer: A retrospective analysis of treatment-related complications and side effects
  38. Psychometric evaluation of the Danish version of the Pain Self-Efficacy Questionnaire in patients with subacute and chronic low back pain
  39. Dimensionality, reliability, and validity of the Finnish version of the pain catastrophizing scale in chronic low back pain
  40. To speak or not to speak? A secondary data analysis to further explore the context-insensitive avoidance scale
  41. Pain catastrophizing levels differentiate between common diseases with pain: HIV, fibromyalgia, complex regional pain syndrome, and breast cancer survivors
  42. Prevalence of substance use disorder diagnoses in patients with chronic pain receiving reimbursed opioids: An epidemiological study of four Norwegian health registries
  43. Pain perception while listening to thrash heavy metal vs relaxing music at a heavy metal festival – the CoPainHell study – a factorial randomized non-blinded crossover trial
  44. Observational Studies
  45. Cutaneous nerve biopsy in patients with symptoms of small fiber neuropathy: a retrospective study
  46. The incidence of post cholecystectomy pain (PCP) syndrome at 12 months following laparoscopic cholecystectomy: a prospective evaluation in 200 patients
  47. Associations between psychological flexibility and daily functioning in endometriosis-related pain
  48. Relationship between perfectionism, overactivity, pain severity, and pain interference in individuals with chronic pain: A cross-lagged panel model analysis
  49. Access to psychological treatment for chronic cancer-related pain in Sweden
  50. Validation of the Danish version of the knowledge and attitudes survey regarding pain
  51. Associations between cognitive test scores and pain tolerance: The Tromsø study
  52. Healthcare experiences of fibromyalgia patients and their associations with satisfaction and pain relief. A patient survey
  53. Video interpretation in a medical spine clinic: A descriptive study of a diverse population and intervention
  54. Role of history of traumatic life experiences in current psychosomatic manifestations
  55. Social determinants of health in adults with whiplash associated disorders
  56. Which patients with chronic low back pain respond favorably to multidisciplinary rehabilitation? A secondary analysis of a randomized controlled trial
  57. A preliminary examination of the effects of childhood abuse and resilience on pain and physical functioning in patients with knee osteoarthritis
  58. Differences in risk factors for flare-ups in patients with lumbar radicular pain may depend on the definition of flare
  59. Real-world evidence evaluation on consumer experience and prescription journey of diclofenac gel in Sweden
  60. Patient characteristics in relation to opioid exposure in a chronic non-cancer pain population
  61. Topical Reviews
  62. Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
  63. What do we know about Indigenous Peoples with low back pain around the world? A topical review
  64. The “future” pain clinician: Competencies needed to provide psychologically informed care
  65. Systematic Reviews
  66. Pain management for persistent pain post radiotherapy in head and neck cancers: systematic review
  67. High-frequency, high-intensity transcutaneous electrical nerve stimulation compared with opioids for pain relief after gynecological surgery: a systematic review and meta-analysis
  68. Reliability and measurement error of exercise-induced hypoalgesia in pain-free adults and adults with musculoskeletal pain: A systematic review
  69. Noninvasive transcranial brain stimulation in central post-stroke pain: A systematic review
  70. Short Communications
  71. Are we missing the opioid consumption in low- and middle-income countries?
  72. Association between self-reported pain severity and characteristics of United States adults (age ≥50 years) who used opioids
  73. Could generative artificial intelligence replace fieldwork in pain research?
  74. Skin conductance algesimeter is unreliable during sudden perioperative temperature increases
  75. Original Experimental
  76. Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up
  77. Pain catastrophizing in the elderly: An experimental pain study
  78. Improving general practice management of patients with chronic musculoskeletal pain: Interdisciplinarity, coherence, and concerns
  79. Concurrent validity of dynamic bedside quantitative sensory testing paradigms in breast cancer survivors with persistent pain
  80. Transcranial direct current stimulation is more effective than pregabalin in controlling nociceptive and anxiety-like behaviors in a rat fibromyalgia-like model
  81. Paradox pain sensitivity using cuff pressure or algometer testing in patients with hemophilia
  82. Physical activity with person-centered guidance supported by a digital platform or with telephone follow-up for persons with chronic widespread pain: Health economic considerations along a randomized controlled trial
  83. Measuring pain intensity through physical interaction in an experimental model of cold-induced pain: A method comparison study
  84. Pharmacological treatment of pain in Swedish nursing homes: Prevalence and associations with cognitive impairment and depressive mood
  85. Neck and shoulder pain and inflammatory biomarkers in plasma among forklift truck operators – A case–control study
  86. The effect of social exclusion on pain perception and heart rate variability in healthy controls and somatoform pain patients
  87. Revisiting opioid toxicity: Cellular effects of six commonly used opioids
  88. Letter to the Editor
  89. Post cholecystectomy pain syndrome: Letter to Editor
  90. Response to the Letter by Prof Bordoni
  91. Response – Reliability and measurement error of exercise-induced hypoalgesia
  92. Is the skin conductance algesimeter index influenced by temperature?
  93. Skin conductance algesimeter is unreliable during sudden perioperative temperature increase
  94. Corrigendum
  95. Corrigendum to “Chronic post-thoracotomy pain after lung cancer surgery: a prospective study of preoperative risk factors”
  96. Obituary
  97. A Significant Voice in Pain Research Björn Gerdle in Memoriam (1953–2024)
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/sjpain-2023-0124/html
Scroll to top button